Roy J. Sturgeon, Ph.D., Chairman of the Board of Lachman Consultants. Roy began his career at Lachman Consultants as Executive Vice President of the Compliance Practice. He progressed to the position of President and became a Senior Advisor and Outside Director to the Board after retirement. In his current role, he is responsible for working with […]
Frances Zipp, President & CEO of Lachman Consultants who provides expert guidance to the pharmaceutical, biologic and biotechnology industries. Ms. Zipp joined Lachman after a 30-year career in the industry, where she held significant positions of responsibility for Quality and GxP Compliance, including various positions in drug development, operations, quality and regulatory affairs. Ms. Zipp […]
David Petshaft, Esq., Chief Legal and Financial Officer of Lachman Consultants, and in this position oversees and manages the legal and financial affairs and activities of the firm. He also serves on the Board of Directors as the Treasurer/Secretary of the firm. His responsibilities include direct oversight and management of corporate activities relating to the […]
Linda Evans O’Connor, M.B.A., As Vice President, Chief of Staff at Lachman Consultants, Linda Evans O’Connor oversees and manages critical operational activities that include project oversight/management, work planning and workflow analysis, and quality assurance. Ms. O’Connor has a deep understanding of the pharmaceutical industry and delivers thought leadership on client projects. She maintains current industry […]
John McShane, M.B.A., Vice President, Cell & Gene Therapy, Compliance and Business Development at Lachman Consultants, oversees and manages the Cell & Gene Therapy division within the Compliance Practice Group. An accomplished professional, Mr. McShane has extensive industry experience in international biopharmaceuticals, cell and gene therapy, and biotechnology. His distinguished career spans traditional pharmaceutical modalities […]
David G. Lonza, CBA, CQE, CSQE, is Executive Director of Emerging Markets at Lachman Consultants. Mr. Lonza is a leader with significant regional and global management experience who understands the complexities involved in the international pharma industry. He has a successful track record building and directing organizations and is recognized as an exceptional leader with […]
Ricki A. Chase, M.S., is Executive Director in the Compliance Practice at Lachman Consultants. She is an expert in Food and Drug Law, Compliance Law, and Current Good Manufacturing Practices. Ms. Chase has served in leadership development positions in all regulated program areas, including pharmaceuticals, medical devices, human and animal foods, biomonitoring, veterinary medicine, biologics, […]
John Darby, M.Sc., Senior Director in the Compliance practice at Lachman Consultants. Mr. Darby is a goal directed, results-focused executive professional with a strong, global background in quality assurance, compliance, audits, training, and remediation. His 18+ years of experience and keen insight contribute to his ability to identify issues and form innovative solutions and strategies […]
Paul Mason, Ph.D., is a Director in the Science and Technology Practice at Lachman Consultants who has 20+ years of experience in the pharmaceutical industry. He is a Quality Control chemist experienced in sterile parenteral, API, and solid oral dosage forms. His experience spans finished dosage form, CMOs, and API (intermediates) manufacture support in both […]
Nadia Hanoune, Director, Corporate & Financial Affairs at Lachman Consultants, and, in this position, works with David Petshaft, Chief Legal and Financial Officer to oversee and manage the functioning of corporate departments including Accounting, Legal, IT, HR, Travel, and Support Services. Ms. Hanoune has been with Lachman Consultants since 2010 and, under her leadership, produces […]